Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma.

Yanan PengChang LiuMengting LiWenjie LiMengna ZhangXiang JiangYing ChangLan LiuFan WangQiu Zhao

Published in: Cancer cell international (2021)

In a word, we constructed and validated a novel, immune-related prognostic signature for HCC patients. This signature could effectively indicate HCC patients' survival and immunotherapy response. And it might act as potential immunotherapeutic targets for HCC patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
risk assessment
patient reported
drug induced